A new heterocyclic bioreductive bis-alkylating agent, 2,3-bis(chloromethyl)benzo[g] q u i n o x a l i n e -5 , 1 0 -dione, was prepared in a four-steps synthesis. It was shown to react under electron transfer conditions with 2-nitropropane anion by an bis-S RN 1 mechanism to give three C-alkylation products in excellent yields. Extension of this bis-S RN 1 reaction to various nitronate or malonate anions and S-centered anions led to a new class of potentially active benzo[g]quinoxaline-5,10-dione derivatives. . Thus the diazanaphthoquinones were proved to be the most active compounds in comparison with naphthoquinone and quinolinedione. It was published that 5,8-quinoxalinediones that have one additional nitrogen in the different nucleus from quinolinedione showed antitumor activity [5]. Another structural requirement for the antitumor activity is the p-quinone moiety in the nonheterocyclic ring, whereas o-quinone gave decreased activity [6]. The electron-withdrawing groups at the 6 and 7 positions of quinolinediones also contributed to the activity [7], Giorgi-Renault prepared benzoquinoxalinediones and pyridoquinoxalinediones, which are quinoxalinediones fused with benzene or pyridine, and examined their cytotoxic properties [8].In continuation to our studies directed toward the synthesis of new nitroheterocyclic or quinonic bioreductible alkylating agents [9] using single electron transfer reactions, we have investigated the reactivity of 2,3-bis-( c h l o r o m e t h y l ) b e n z o [g]quinoxaline-5,10-dione (5) with various aliphatic or cyclic nitronate anions, malonate and S-centered anions in order to prepare original benzo[g]-quinoxaline-5,10-dione derivatives.